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NCEZID: Protecting People from Infectious Disease
• Foodborne, waterborne, and fungal  
illnesses
• Vector-borne diseases  -- spread by 
mosquitoes, ticks, and fleas
• Healthcare-associated infections
• Antibiotic-resistant infections
• Illnesses that affect immigrants, 
migrants, refugees, and travelers
• Deadly diseases like anthrax and Ebola
• Advanced Molecular Detection
Signature Programs
Strengthening State and Local Capacity
Epidemiology and Laboratory Capacity Grants
• ELC: CDC’s national funding strategy 
for combatting domestic infectious 
disease threats
• Strengthen epidemiological 
capacity
• Enhance laboratory capacity
• Improve health information 
systems
• Support to 64 health departments in 
states, large cities and territories for 
>20 infectious disease programs 
(e.g., flu, foodborne, healthcare-
associated infections)
Emerging Infections Program (EIP)
 Network of 10 state 
health departments 
and university partners 
 Translates gold-
standard surveillance 
into policy and public 
health practice
 Examples:




• HAI and antimicrobial 
resistance
Responding to Outbreaks in the United States
Other examples of NCEZID assisting states in investigations since December 2016
• Kentucky:  CRE (carbapenem-resistant Enterobacteriaceae) infections
• New York:  Possible ongoing transmission of Candida auris in healthcare facilities
• Iowa: Bacteria-contaminated organ preservation fluid
• Wisconsin, Illinois: Seoul virus infection linked to pet rat-breeding facilities
• Arizona:  Zoonotic spread of leptospirosis from dogs to people
• Arkansas: Increased number of laboratory reports for Lyme disease
• Alaska:  Invasive group A Streptococcus infection among homeless people 
 NCEZID works with states to investigate many infectious 
disease outbreaks each year
 Example of 2017 multistate outbreak investigation:
• Worked with states using PulseNet to identify a fast-
moving outbreak of Shiga toxin-producing Escherichia 
coli O157:H7 infections, mostly in children
• Identified source within 8 days: soy nut butter 
Image of soy nut butter
• Company quickly recalled all varieties of its soy nut butter products.
• As of March 30:  29 cases (12 hospitalizations, no deaths) in 12 states
Responding to US Outbreaks: Domestic Zika Response
14 months into most complex CDC 
response ever
Key objective is to support state 
and local jurisdictions in Zika 
prevention, including $184M in 
awards 
 Improve laboratory diagnostics
Monitor pregnant women with 
Zika infection and their babies
 Implement robust vector 
surveillance and control programs
NCEZID Laboratories – A Critical Public Health Resource
NCEZID manages a broad array of specialized 
labs and nationwide lab networks. Examples: 
 PulseNet: US lab network that detects 
foodborne disease outbreaks, prevents 
270,000 illnesses each year
 Laboratory Response Network: Responds 
quickly to biological threats and other public 
health emergencies
 Infectious Disease Pathology Lab: Conducts 
specialized studies of human tissues and 
diseases of unknown origin
Biotech Core Facility:  Provides advanced 
sequencing and other technology support 
High-Containment Lab:  Conducts research 
on BSL-4 pathogens (e.g., Ebola)
MicrobeNet:  Improving Patient Outcomes by Helping 
Laboratories Match Test Results
 Online database with information on more than 2,400 
rare disease-causing microbes
• Genetic sequence information
• Biochemical characterization (what enzymes and nutrients 
does the pathogen use)
• Morphological characterization (how does the pathogen 
grow: size, shape, and color of colonies)
• Antibiotic resistance profiles
 Allows public health and clinical laboratories anywhere in 
the world to match results from their diagnostic tests 
against CDC’s unique collection of pathogens
Antibiotic Resistance: An Emerging Threat
Sickens >2 million people and kills 
at least 23,000 people each year
>$20 billion each year in healthcare 
costs
Threatens modern medicine – if we 
lose antibiotics, we lose the ability 
to treat patients with sepsis and 
cancer, provide organ transplants 
and save victims of burns and 
trauma
Need to act now or even drugs of 
last resort will soon be ineffective
CDC Investments to Combat Antibiotic Resistance (AR)
 CDC investments with partners are intended to transform how the US 
fights AR and slows resistance at all levels  
 $160M in FY 2016 AR investments to Detect, Respond, Contain, Prevent 
and Innovate 
 AR Laboratory Network
 Support provided to every state. In Jan 2017 CDC launched interactive AR 
investment map: https://wwwn.cdc.gov/arinvestments






Examples of AMD in Action: 
 Zika virus diagnostic development
 HIV outbreak in Indiana
 Influenza monitoring for vaccine 
development
 Emergence of Candida auris strains
Advanced Molecular 
Detection (AMD):
 Established by Congress 
in FY2014
 $30 million per year
 Innovation and 
modernization program
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Examples of AMD Successes and Impact
Bacterial Foodborne Illness Expanding PulseNet whole genome sequencing (WGS) to
E. coli, Shigella, Campylobacter, Salmonella, others
Tuberculosis WGS of all 10,000 U.S. TB isolates to identify locally 
acquired cases and better understand transmission; 
rapid inference of drug susceptibility 
Influenza Change to “sequencing-first” approach has 
revolutionized how influenza viruses are characterized
Antibiotic Resistance Better understanding of emergence of antibiotic-
resistant organisms such as CRE and C. auris
Zika and other mosquito-borne 
viruses
Methods developed under AMD to monitor Dengue and 
Chikungunya viruses in the Americas were used to 
rapidly develop a molecular Zika virus assay early in the 
outbreak
Hepatitis C virus Special methods developed, validated and now being 
rolled out to state health departments for monitoring 
HCV transmission and detecting outbreaks
Legionella WGS now being used to better understand the 96% of 
Legionella cases that are sporadic
Quarantine Stations at 20 U.S. Ports of 
Entry
Final Rule for Control of Communicable 
Diseases became effective March 21
 Improves CDC’s ability to protect against 
introduction and spread of communicable 
diseases
Travelers’ Health - U.S. residents 
traveling abroad
 Immigrant, refugee, and migrant health 
– guidelines, screen/treat, track 
diseases
Protecting Against Importation of Infectious Diseases
For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY:  1-888-232-6348    www.cdc.gov
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